Scott Kelley Flexion Therapeutics Inc (FLXN) insider trading activity
Scott Kelley is Chief Medical Officer of Flexion Therapeutics Inc. Currently has a direct ownership of 143,549 shares of FLXN, which is worth approximately $1.31 Million. The most recent transaction as insider was on Mar 01, 2021, when has been sold 30,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
144K
0%
3M change
0%
12M change
Total Value Held
$1.31 Million
SK
Scott Kelley
Chief Medical Officer
Burlington, MA